A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: ZPL-5212372 1% w/w Ointment BIDDrug: Placebo Ointment BID
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2019-04-05
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT02795832
- Locations
- 🇬🇧
MAC, Manchester, United Kingdom
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 129
- Registration Number
- NCT02618616
- Locations
- 🇧🇪
Belgium Study Centre, Liège, Belgium
🇵🇱Polish Study Centre, Łódź, Poland
🇬🇧UK Study Centre, Manchester, United Kingdom
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis
- First Posted Date
- 2015-04-23
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 98
- Registration Number
- NCT02424253
- Locations
- 🇩🇪
German Study Site, Munster, Germany
🇧🇪Belgium Study Site, Liege, Belgium
🇬🇧UK Study Centre, Manchester, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath